Bernstein’s MD, Venugopal Garre, maintains a positive outlook on the Indian market with a Nifty target of 26,500, citing improvements in macro conditions and potential rate cuts. Despite global uncertainties and trade tensions, Garre anticipates better capital expenditure and consumption, though not enough for extraordinary returns. Portfolio strategy emphasizes domestic recovery candidates with some defensiveness, overweighting financials, telecom, and utilities.
Tata Chemicals surges on Tata Sons listing buzz
Tata Chemicals shares surged on Thursday, driven by the RBI’s new guidelines for upper-layer NBFCs, sparking hopes for a Tata Sons listing. Analysts suggest this
June 26, 2026